Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
802 Views
eMediNexus 30 January 2023
This investigation suggests that discontinuing RAS inhibitors does not cause significant between-group discrepancies in the long-term rate of decrease in the eGFR among patients with advanced and progressive chronic kidney disease.
Reference- Bhandari S, Mehta S, Khwaja A, et al. Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease. New England Journal of Medicine. 2022;387(22):2021-2032. https://www.nejm.org/doi/full/10.1056/NEJMoa2210639
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}